These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9195550)

  • 21. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins.
    Cockshutt AM; Absolom DR; Possmayer F
    Biochim Biophys Acta; 1991 Sep; 1085(2):248-56. PubMed ID: 1892895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical properties and surface activity of surfactant-like membranes containing the cationic and hydrophobic peptide KL4.
    Sáenz A; Cañadas O; Bagatolli LA; Johnson ME; Casals C
    FEBS J; 2006 Jun; 273(11):2515-27. PubMed ID: 16704424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of bilirubin on surface tension properties of lung surfactant.
    Amato M; Schürch S; Grunder R; Bachofen H; Burri PH
    Arch Dis Child Fetal Neonatal Ed; 1996 Nov; 75(3):F191-6. PubMed ID: 8976686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):855-61. PubMed ID: 9310004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.
    Revak SD; Merritt TA; Cochrane CG; Heldt GP; Alberts MS; Anderson DW; Kheiter A
    Pediatr Res; 1996 Apr; 39(4 Pt 1):715-24. PubMed ID: 8848350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic surface tension of surfactant TA: experiments and theory.
    Otis DR; Ingenito EP; Kamm RD; Johnson M
    J Appl Physiol (1985); 1994 Dec; 77(6):2681-8. PubMed ID: 7896607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
    Strayer DS; Herting E; Sun B; Robertson B
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.
    Qiu Y; Chow MYT; Liang W; Chung WWY; Mak JCW; Lam JKW
    Mol Pharm; 2017 Dec; 14(12):4606-4617. PubMed ID: 29121767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of model human pulmonary surfactants with a mixed phospholipid bilayer assembly: Raman spectroscopic studies.
    Vincent JS; Revak SD; Cochrane CD; Levin IW
    Biochemistry; 1993 Aug; 32(32):8228-38. PubMed ID: 8347622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial pulmonary surfactant inhibited by proteins.
    Fuchimukai T; Fujiwara T; Takahashi A; Enhorning G
    J Appl Physiol (1985); 1987 Feb; 62(2):429-37. PubMed ID: 3558203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein-lipid interactions and enzyme requirements for light subtype generation on cycling reconstituted surfactant.
    Dhand R; Sharma VK; Teng AL; Krishnasamy S; Gross NJ
    Biochem Biophys Res Commun; 1998 Mar; 244(3):712-9. PubMed ID: 9535730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant.
    Kakinuma R; Shimizu H; Ogawa Y
    Eur J Pediatr; 2002 Jan; 161(1):31-6. PubMed ID: 11808878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity.
    Veldhuizen RA; Hearn SA; Lewis JF; Possmayer F
    Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):519-24. PubMed ID: 8002958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of oxyradicals on surfactant function: utilizing in vitro Fenton reaction.
    Amirkhanian JD; Merritt TA
    Lung; 1998; 176(1):63-72. PubMed ID: 9436178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine proteinase requirement for the extra-cellular metabolism of pulmonary surfactant.
    Gross NJ; Schultz RM
    Biochim Biophys Acta; 1990 May; 1044(2):222-30. PubMed ID: 2344440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.
    Cochrane CG; Revak SD; Merritt TA; Heldt GP; Hallman M; Cunningham MD; Easa D; Pramanik A; Edwards DK; Alberts MS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):404-10. PubMed ID: 8542150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.